Concord Medical Group PRIME

New York, New York 10016

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials